Immuno Oncology Assays Market 2028 By Technology, Indication, Application | The Insight Partners

    Immuno Oncology Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Immunoassays, PCR, NGS, Flow Cytometry, Others); Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, Others); Application (Clinical Diagnostics, Research)

    Report Code: TIPRE00006575 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

    MARKET OVERVIEW

    Immuno oncology assays include the use of various immunology assays to monitor the interaction between immune cells and cancer cells. The human body's immune system has a great potential to destroy tumor cells producing no toxicity to normal cells. Moreover, the immune system also can prevent the recurrence of cancer.

    MARKET SCOPE

    The "Global Immuno Oncology Assays Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the immuno oncology assays market with detailed market segmentation by technology, indication, application, and geography. The report provides key statistics on the market status of the leading immuno oncology assays market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    •   Based on technology, the global immuno oncology assays market is segmented into immunoassays, PCR, NGS, flow cytometry, others.
    •   Based on indication, the global immuno oncology assays market is segmented into colorectal cancer, lung cancer, melanoma, bladder cancer, others
    •   Based on application, the market is bifurcated into clinical diagnostics, research.
      ?

    MARKET DYNAMICS
    Drivers:

    •   Rising incidence of cancer and growing adoption of targeted therapies
    •   Increased demand for personalized medicine
    •   Growing patient preference towards immunotherapies and immunodiagnostics

    Restraints:

    •   Requirement of high capital investments and low cost-benefit ratio
    •   Unfavorable regulatory and reimbursement scenario
    •   High cost of immunotherapy



    Get more information on this report :

    REGIONAL FRAMEWORK


    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The immuno oncology assays market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

    The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the immuno oncology assays market in these regions.

    IMPACT OF COVID-19 ON IMMUNO ONCOLOGY ASSAYS MARKET

    COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
    Numerous patients pretended with COVID-19 were people with malignancies. Investigation in this area is further undertaken to understand better the infection dynamics, which is expected to drive the cancer research field. The shift in demand for research on COVID-19 and oncology has created considerable scope for testing solutions, such as assays and profiling panel testing outcomes. This is further anticipated to drive the demand for immuno-oncology assays and instruments.



    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the immuno oncology assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from immuno oncology assays market are anticipated to lucrative growth opportunities in the future with the rising demand for immuno oncology assays in the global market.

    The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the immuno oncology assays market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    •   Agilent Technologies, Inc.
    •   F. Hoffmann-La Roche Ltd
    •   HTG Molecular Diagnostics, Inc.
    •   Illumina, Inc.
    •   Merck KGaA
    •   PerkinElmer Inc.
    •   Thermo Fisher Scientific Inc.
    •   Qiagen
    •   Sartorius AG
    •   NanoString Technologies, Inc.
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Immuno Oncology Assays Market - By Technology
    1.3.2 Immuno Oncology Assays Market - By Indication
    1.3.3 Immuno Oncology Assays Market - By Application
    1.3.4 Immuno Oncology Assays Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. IMMUNO ONCOLOGY ASSAYS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. IMMUNO ONCOLOGY ASSAYS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. IMMUNO ONCOLOGY ASSAYS MARKET - GLOBAL MARKET ANALYSIS
    6.1. IMMUNO ONCOLOGY ASSAYS - GLOBAL MARKET OVERVIEW
    6.2. IMMUNO ONCOLOGY ASSAYS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING
    7. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
    7.1. OVERVIEW
    7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
    7.3. IMMUNOASSAYS
    7.3.1. Overview
    7.3.2. Immunoassays Market Forecast and Analysis
    7.4. PCR
    7.4.1. Overview
    7.4.2. PCR Market Forecast and Analysis
    7.5. NGS
    7.5.1. Overview
    7.5.2. NGS Market Forecast and Analysis
    7.6. FLOW CYTOMETRY
    7.6.1. Overview
    7.6.2. Flow Cytometry Market Forecast and Analysis
    7.7. OTHERS
    7.7.1. Overview
    7.7.2. Others Market Forecast and Analysis
    8. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
    8.1. OVERVIEW
    8.2. INDICATION MARKET FORECASTS AND ANALYSIS
    8.3. COLORECTAL CANCER
    8.3.1. Overview
    8.3.2. Colorectal Cancer Market Forecast and Analysis
    8.4. LUNG CANCER
    8.4.1. Overview
    8.4.2. Lung Cancer Market Forecast and Analysis
    8.5. MELANOMA
    8.5.1. Overview
    8.5.2. Melanoma Market Forecast and Analysis
    8.6. BLADDER CANCER
    8.6.1. Overview
    8.6.2. Bladder Cancer Market Forecast and Analysis
    8.7. OTHERS
    8.7.1. Overview
    8.7.2. Others Market Forecast and Analysis
    9. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    9.1. OVERVIEW
    9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    9.3. CLINICAL DIAGNOSTICS
    9.3.1. Overview
    9.3.2. Clinical Diagnostics Market Forecast and Analysis
    9.4. RESEARCH
    9.4.1. Overview
    9.4.2. Research Market Forecast and Analysis
    10. IMMUNO ONCOLOGY ASSAYS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Immuno Oncology Assays Market Overview
    10.1.2 North America Immuno Oncology Assays Market Forecasts and Analysis
    10.1.3 North America Immuno Oncology Assays Market Forecasts and Analysis - By Technology
    10.1.4 North America Immuno Oncology Assays Market Forecasts and Analysis - By Indication
    10.1.5 North America Immuno Oncology Assays Market Forecasts and Analysis - By Application
    10.1.6 North America Immuno Oncology Assays Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Immuno Oncology Assays Market
    10.1.6.1.1 United States Immuno Oncology Assays Market by Technology
    10.1.6.1.2 United States Immuno Oncology Assays Market by Indication
    10.1.6.1.3 United States Immuno Oncology Assays Market by Application
    10.1.6.2 Canada Immuno Oncology Assays Market
    10.1.6.2.1 Canada Immuno Oncology Assays Market by Technology
    10.1.6.2.2 Canada Immuno Oncology Assays Market by Indication
    10.1.6.2.3 Canada Immuno Oncology Assays Market by Application
    10.1.6.3 Mexico Immuno Oncology Assays Market
    10.1.6.3.1 Mexico Immuno Oncology Assays Market by Technology
    10.1.6.3.2 Mexico Immuno Oncology Assays Market by Indication
    10.1.6.3.3 Mexico Immuno Oncology Assays Market by Application
    10.2. EUROPE
    10.2.1 Europe Immuno Oncology Assays Market Overview
    10.2.2 Europe Immuno Oncology Assays Market Forecasts and Analysis
    10.2.3 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Technology
    10.2.4 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Indication
    10.2.5 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Application
    10.2.6 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Immuno Oncology Assays Market
    10.2.6.1.1 Germany Immuno Oncology Assays Market by Technology
    10.2.6.1.2 Germany Immuno Oncology Assays Market by Indication
    10.2.6.1.3 Germany Immuno Oncology Assays Market by Application
    10.2.6.2 France Immuno Oncology Assays Market
    10.2.6.2.1 France Immuno Oncology Assays Market by Technology
    10.2.6.2.2 France Immuno Oncology Assays Market by Indication
    10.2.6.2.3 France Immuno Oncology Assays Market by Application
    10.2.6.3 Italy Immuno Oncology Assays Market
    10.2.6.3.1 Italy Immuno Oncology Assays Market by Technology
    10.2.6.3.2 Italy Immuno Oncology Assays Market by Indication
    10.2.6.3.3 Italy Immuno Oncology Assays Market by Application
    10.2.6.4 Spain Immuno Oncology Assays Market
    10.2.6.4.1 Spain Immuno Oncology Assays Market by Technology
    10.2.6.4.2 Spain Immuno Oncology Assays Market by Indication
    10.2.6.4.3 Spain Immuno Oncology Assays Market by Application
    10.2.6.5 United Kingdom Immuno Oncology Assays Market
    10.2.6.5.1 United Kingdom Immuno Oncology Assays Market by Technology
    10.2.6.5.2 United Kingdom Immuno Oncology Assays Market by Indication
    10.2.6.5.3 United Kingdom Immuno Oncology Assays Market by Application
    10.2.6.6 Rest of Europe Immuno Oncology Assays Market
    10.2.6.6.1 Rest of Europe Immuno Oncology Assays Market by Technology
    10.2.6.6.2 Rest of Europe Immuno Oncology Assays Market by Indication
    10.2.6.6.3 Rest of Europe Immuno Oncology Assays Market by Application
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Immuno Oncology Assays Market Overview
    10.3.2 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis
    10.3.3 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Technology
    10.3.4 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Indication
    10.3.5 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Application
    10.3.6 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Immuno Oncology Assays Market
    10.3.6.1.1 Australia Immuno Oncology Assays Market by Technology
    10.3.6.1.2 Australia Immuno Oncology Assays Market by Indication
    10.3.6.1.3 Australia Immuno Oncology Assays Market by Application
    10.3.6.2 China Immuno Oncology Assays Market
    10.3.6.2.1 China Immuno Oncology Assays Market by Technology
    10.3.6.2.2 China Immuno Oncology Assays Market by Indication
    10.3.6.2.3 China Immuno Oncology Assays Market by Application
    10.3.6.3 India Immuno Oncology Assays Market
    10.3.6.3.1 India Immuno Oncology Assays Market by Technology
    10.3.6.3.2 India Immuno Oncology Assays Market by Indication
    10.3.6.3.3 India Immuno Oncology Assays Market by Application
    10.3.6.4 Japan Immuno Oncology Assays Market
    10.3.6.4.1 Japan Immuno Oncology Assays Market by Technology
    10.3.6.4.2 Japan Immuno Oncology Assays Market by Indication
    10.3.6.4.3 Japan Immuno Oncology Assays Market by Application
    10.3.6.5 South Korea Immuno Oncology Assays Market
    10.3.6.5.1 South Korea Immuno Oncology Assays Market by Technology
    10.3.6.5.2 South Korea Immuno Oncology Assays Market by Indication
    10.3.6.5.3 South Korea Immuno Oncology Assays Market by Application
    10.3.6.6 Rest of Asia-Pacific Immuno Oncology Assays Market
    10.3.6.6.1 Rest of Asia-Pacific Immuno Oncology Assays Market by Technology
    10.3.6.6.2 Rest of Asia-Pacific Immuno Oncology Assays Market by Indication
    10.3.6.6.3 Rest of Asia-Pacific Immuno Oncology Assays Market by Application
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Immuno Oncology Assays Market Overview
    10.4.2 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis
    10.4.3 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Technology
    10.4.4 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Indication
    10.4.5 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Application
    10.4.6 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Immuno Oncology Assays Market
    10.4.6.1.1 South Africa Immuno Oncology Assays Market by Technology
    10.4.6.1.2 South Africa Immuno Oncology Assays Market by Indication
    10.4.6.1.3 South Africa Immuno Oncology Assays Market by Application
    10.4.6.2 Saudi Arabia Immuno Oncology Assays Market
    10.4.6.2.1 Saudi Arabia Immuno Oncology Assays Market by Technology
    10.4.6.2.2 Saudi Arabia Immuno Oncology Assays Market by Indication
    10.4.6.2.3 Saudi Arabia Immuno Oncology Assays Market by Application
    10.4.6.3 U.A.E Immuno Oncology Assays Market
    10.4.6.3.1 U.A.E Immuno Oncology Assays Market by Technology
    10.4.6.3.2 U.A.E Immuno Oncology Assays Market by Indication
    10.4.6.3.3 U.A.E Immuno Oncology Assays Market by Application
    10.4.6.4 Rest of Middle East and Africa Immuno Oncology Assays Market
    10.4.6.4.1 Rest of Middle East and Africa Immuno Oncology Assays Market by Technology
    10.4.6.4.2 Rest of Middle East and Africa Immuno Oncology Assays Market by Indication
    10.4.6.4.3 Rest of Middle East and Africa Immuno Oncology Assays Market by Application
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Immuno Oncology Assays Market Overview
    10.5.2 South and Central America Immuno Oncology Assays Market Forecasts and Analysis
    10.5.3 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Technology
    10.5.4 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Indication
    10.5.5 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Application
    10.5.6 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Immuno Oncology Assays Market
    10.5.6.1.1 Brazil Immuno Oncology Assays Market by Technology
    10.5.6.1.2 Brazil Immuno Oncology Assays Market by Indication
    10.5.6.1.3 Brazil Immuno Oncology Assays Market by Application
    10.5.6.2 Argentina Immuno Oncology Assays Market
    10.5.6.2.1 Argentina Immuno Oncology Assays Market by Technology
    10.5.6.2.2 Argentina Immuno Oncology Assays Market by Indication
    10.5.6.2.3 Argentina Immuno Oncology Assays Market by Application
    10.5.6.3 Rest of South and Central America Immuno Oncology Assays Market
    10.5.6.3.1 Rest of South and Central America Immuno Oncology Assays Market by Technology
    10.5.6.3.2 Rest of South and Central America Immuno Oncology Assays Market by Indication
    10.5.6.3.3 Rest of South and Central America Immuno Oncology Assays Market by Application
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Middle East and Africa
    11.5 South and Central America
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. IMMUNO ONCOLOGY ASSAYS MARKET, KEY COMPANY PROFILES
    13.1. AGILENT TECHNOLOGIES, INC.
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. F. HOFFMANN-LA ROCHE LTD
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. HTG MOLECULAR DIAGNOSTICS, INC.
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. ILLUMINA, INC.
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. MERCK KGAA
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. PERKINELMER INC.
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. THERMO FISHER SCIENTIFIC INC.
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. QIAGEN
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. SARTORIUS AG
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. NANOSTRING TECHNOLOGIES, INC.
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    1. Agilent Technologies, Inc.
    2. F. Hoffmann-La Roche Ltd
    3. HTG Molecular Diagnostics, Inc.
    4. Illumina, Inc.
    5. Merck KGaA
    6. PerkinElmer Inc.
    7. Thermo Fisher Scientific Inc.
    8. Qiagen
    9. Sartorius AG
    10. NanoString Technologies, Inc.
    11. Biomerieux SA
    12. Myriad Genetics, Inc.
    13. Guardant Health, Inc.
    14. Bio-Rad Laboratories, Inc.
    15. Seegene Inc.
    16. Meso Scale Diagnostics, LLC
    17. Olink
    18. Asuragen, Inc.
    19. Invivoscribe, Inc.
    20. Creative Biolabs
    TIPRE00006575
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount